Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: A comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 6, 2005, Pages 641-647

  Di Fiore, Frédéric ^a,h   Lecleire, Stéphane ^a   Merle, Véronique ^a   Hervé, Sophie ^a   Duhamel, Christian ^b   Dupas, Jean Louis ^c   Vandewalle, Alain ^c   Bental, Abdeslam ^d   Gouerou, Hervé ^e   Le Page, Maryvonne ^f   Amouretti, Michel ^g   Czernichow, Pierre ^a   Lerebours, Eric ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b LE HAVRE HOSPITAL   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d Abbeville Hospital   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f Department of Hepatogastroenterology   (France)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Epidemiology; Upper gastrointestinal haemorrhage

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; FRANCE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEPTIC ULCER; PRIORITY JOURNAL; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COMORBIDITY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FRANCE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 21144448328     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200506000-00008     Document Type: Article

References (28)

1. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastro-intestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997; 315:510-514.
2. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Screening Committee and members at the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311:222-226.
3. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GN. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997; 92:236-243.
4. van Leerdam ME, Vreeburg EM, Rauws EAJ, Geraedts AA, Tijssen JG, Reitsma JB, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98:1494-1499.
5. Amouretti M, Czernichow P, Kerjean A, Hochain P, Nousbaum JB, Rudelli A, et al. Management of upper digestive hemorrhage occurring in the community: patterns of patient care in 4 French administrative areas. Gastroenterol Clin Biol 2000; 24:1003-1011.
6. Czernichow P, Hochain P, Nousbaum JB, Raymond JM, Rudelli A, Dupas JL, et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepat 2000; 12:175-181.
7. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population based study. Am J Gastroenterol 1995; 90:206-210.
8. Thomopoulos K, Vagenas K, Vagianos C, Margaritis VG, Blikas AP, Katsakoulis EC, et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol 2004; 16:177-182.
9. Thomopoulos K, Kastakoulis E, Vagianos C, Mimidis K, Margaritis V, Nikolopoulou V. Causes and clinical outcome of acute upper gastrointestinal bleeding: a prospective analysis of 1534 cases. Int J Clin Pract 1998; 52:547-550.
10. Longstreth GF, Feitelberg SP. Hospital care of acute nonvariceal upper gastrointestinal bleeding in 1991 vs 1981. J Clin Gastroenterol 1994; 19:189-193.
11. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Influencing the practice and outcome in acute variation in outcome gastrointestinal haemorrhage. Steering Committee of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Gut 1997; 41:606-611.
12. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1995; 346:346-350.
13. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38:316-321.
14. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996; 347:1138-1140.
15. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series. Gastrointest Endosc 1998; 47:219-222.
16. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000; 356:1318-1321.
17. Dixon WJ. BMDP statistical software. Berkeley: University of California Press; 1990. pp. 19-90.
18. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. Acid suppression trial: ranitidine vs omeprazole for NSAIDS-associated ulcer treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338:719-726.
19. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole vs misoprostol for NSAIDS-induced ulcer management (OMNIUM) Study Group. N Engl J Med 1998; 338:727-734.
20. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, et al. Peptic ulcer bleeding: accessory risk factors and interactions steroidal antiinflammatory drugs. Gut 2000; 46:27-31.
21. Hawkey CJ, Laine L, Simon T, Quan H, Shingo S, Evans J. Rofecoxib Rheumatoid Arthritis Endoscopy Study Group. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. Gut 2003; 52:820-826.
22. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Underutilization of preventive strategies in patients receiving NSAIDSs. Rheumatology 2003; 42S:23-31.
23. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340:1888-1899.
24. Naveau S, Giraud V, Ganne N, Perney P, Hastier P, Robin E, et al. Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study. Gastroenterol Clin Biol 2001; 25:131-136.
25. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 1997; 92:1081-1091.
26. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of valpreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension. N Engl J Med 2001; 344:23-28.
27. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802-806.
28. Chalasani N, Kahi C, François F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653-659.